<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kim PG</submitter><funding>NCI NIH HHS</funding><pagination>183-197.e9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12933725</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>33(2)</volume><pubmed_abstract>Somatic mutations in TET2 drive hyper-inflammation in clonal hematopoiesis of indeterminate potential (CHIP), but the molecular link between TET2 inactivation and myeloid immune activation remains unclear. We used in vivo genome-wide genetic perturbations enabled by ultra-diverse barcoding in primary wild-type (WT) or Tet2 knockout (KO) Cas9&lt;sup>+&lt;/sup> hematopoietic stem-progenitor cells (HSPCs) to elucidate the basis of Tet2 KO inflammation. We uncover a metabolic circuit by which Tet2 restrains O-linked N-acetylglucosamine (O-GlcNAc) glycosyltransferase (Ogt), a Tet2 binding partner and metabolic sensor. Tet2 loss disrupts this inhibitory Tet2-Ogt interaction, and dysregulated Ogt facilitates widespread H3K4 trimethylation including lipid-related gene loci and inflammatory lipid droplet</pubmed_abstract><journal>Cell chemical biology</journal><pubmed_title>Metabolic control of innate immune activation in TET2-mutant clonal hematopoiesis.</pubmed_title><pmcid>PMC12933725</pmcid><funding_grant_id>P01 CA066996</funding_grant_id><funding_grant_id>R35 CA253125</funding_grant_id><pubmed_authors>Roy Burman SS</pubmed_authors><pubmed_authors>Vander Heiden MG</pubmed_authors><pubmed_authors>Miller AP</pubmed_authors><pubmed_authors>Ebert BL</pubmed_authors><pubmed_authors>Bullock K</pubmed_authors><pubmed_authors>Park P</pubmed_authors><pubmed_authors>Boileau M</pubmed_authors><pubmed_authors>Yue H</pubmed_authors><pubmed_authors>Deik A</pubmed_authors><pubmed_authors>Trinh MN</pubmed_authors><pubmed_authors>Armstrong SA</pubmed_authors><pubmed_authors>Yoon H</pubmed_authors><pubmed_authors>Clish C</pubmed_authors><pubmed_authors>Hergott CB</pubmed_authors><pubmed_authors>Pierce KA</pubmed_authors><pubmed_authors>Rutter JC</pubmed_authors><pubmed_authors>Choy AH</pubmed_authors><pubmed_authors>Ryback BA</pubmed_authors><pubmed_authors>McConkey M</pubmed_authors><pubmed_authors>Loke J</pubmed_authors><pubmed_authors>Shin W</pubmed_authors><pubmed_authors>Kim PG</pubmed_authors><pubmed_authors>Fischer ES</pubmed_authors></additional><is_claimable>false</is_claimable><name>Metabolic control of innate immune activation in TET2-mutant clonal hematopoiesis.</name><description>Somatic mutations in TET2 drive hyper-inflammation in clonal hematopoiesis of indeterminate potential (CHIP), but the molecular link between TET2 inactivation and myeloid immune activation remains unclear. We used in vivo genome-wide genetic perturbations enabled by ultra-diverse barcoding in primary wild-type (WT) or Tet2 knockout (KO) Cas9&lt;sup>+&lt;/sup> hematopoietic stem-progenitor cells (HSPCs) to elucidate the basis of Tet2 KO inflammation. We uncover a metabolic circuit by which Tet2 restrains O-linked N-acetylglucosamine (O-GlcNAc) glycosyltransferase (Ogt), a Tet2 binding partner and metabolic sensor. Tet2 loss disrupts this inhibitory Tet2-Ogt interaction, and dysregulated Ogt facilitates widespread H3K4 trimethylation including lipid-related gene loci and inflammatory lipid droplet</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-16T20:47:46.518Z</modification><creation>2026-07-10T03:12:56.63Z</creation></dates><accession>S-EPMC12933725</accession><cross_references><pubmed>41672066</pubmed><doi>10.1016/j.chembiol.2026.01.006</doi></cross_references></HashMap>